About EuropaBio

 

EuropaBio is the European Association for Bioindustries and was created in 1996. Our mission is to create an innovative and dynamic biotechnology-based industry in Europe.

Our membership is composed of 56 corporate members,13 associate members and Bio regions, and 16 national biotechnology associations, who in turn represent more than 1800 small and medium sized biotech companies in Europe. Members of EuropaBio are involved in research, development, testing, manufacturing and commercialisation of biotechnology products and processes. Our corporate members have a wide range of activities: human and animal health care, diagnostics, bio-informatics, chemicals, crop protection, agriculture, food and environmental products and services.

EuropaBio also welcomes associate members such as international commercial, financial, asset management and other service-providing companies, regional biotechnology development organisations and scientific institutes. The common denominator among all our members is the use of biotechnology at any stage of research, development or manufacturing.

We stand for free and open markets and the removal of barriers to competitiveness with other areas of the world.

We are committed to an open, informed dialogue with all stakeholders and the general public about the ethical, social and economic aspects of biotechnology and its applications.

We champion the responsible use of biotechnology to ensure that its potential is fully used to the benefit of the environment and mankind.

 

What we do

We are actively engaged in raising awareness of the benefits of biotechnology to all corners of society and to increase the knowledge and understanding of our industry. We aim to create a more positive environment in Europe within which biotech industries can flourish. 

We are devoted to repositioning the communications surrounding biotechnology by reaching out to the public through journalists, publications, on line media, events and engaging with industry stakeholders such as farmers and patients.